US 8263606
Spiro-oxindole compounds and their use as therapeutic agents
granted A61PA61P1/00A61P1/02
Quick answer
US patent 8263606 (Spiro-oxindole compounds and their use as therapeutic agents) held by Xenon Pharmaceuticals Inc. expires Mon Sep 06 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Xenon Pharmaceuticals Inc.
- Grant date
- Tue Sep 11 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 06 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 25
- CPC classes
- A61P, A61P1/00, A61P1/02, A61P1/04, A61P11/00